Protocol in Acute Myeloid Leukemia With FLT3-ITD

NCT01477606 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

451

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Midostaurin
DRUG: Cytarabine
DRUG: Daunorubicin

Sponsor

University of Ulm

Collaborators

[object Object]